CD9 has also been shown to play a role in cancer cell extravasation in vivo [16], and transient overexpression of CD9 on the cell surface of MDA-MB-231 breast cancer cells resulted in increased migration [17]. This evidence concerns the gene CD9 and breast carcinoma.